These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25171932)

  • 21. Vemurafenib as first-line therapy in
    Fernández-Eulate G; Muñoz-Lopetegi A; Ruiz I; Urtasun M
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31748352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies.
    Franconieri F; Martin-Silva N; de Boysson H; Galateau-Salle F; Emile JF; Bienvenu B; Aouba A
    Acta Oncol; 2016 Jul; 55(7):930-2. PubMed ID: 27031008
    [No Abstract]   [Full Text] [Related]  

  • 23. [Erdheim-Chester disease].
    Haroche J; Cohen-Aubart F; Arnaud L; Hervier B; Charlotte F; Drier A; Gorochov G; Grenier PA; Cluzel P; Maksud P; Emile JF; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):715-22. PubMed ID: 24878295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 72-year old female with multiple supra- and infratentorial dural masses.
    Kirschenbaum D; Woernle C; Haralambieva E; Marques Maggio E; Bernays R; Camenisch U; Rushing EJ
    Brain Pathol; 2018 Nov; 28(6):1023-1024. PubMed ID: 30536772
    [No Abstract]   [Full Text] [Related]  

  • 25. Intracranial lesion of Erdheim-Chester disease.
    Shimada S; Ono K; Hashizume Y; Nakaguro M; Suzuki Y; Mori N
    Hum Pathol; 2007 Jun; 38(6):950-1. PubMed ID: 17509397
    [No Abstract]   [Full Text] [Related]  

  • 26. [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
    Adam Z; Koukalová R; Sprláková A; Rehák Z; Cervinek L; Szturz P; Krejcí M; Pour L; Zahradová L; Moulis M; Prásek J; Chaloupka R; Hájek R; Mayer J
    Vnitr Lek; 2011 Jun; 57(6):576-89. PubMed ID: 21751544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.
    Alharthi MS; Calleja A; Panse P; Appleton C; Jaroszewski DE; Tazelaar HD; Mookadam F
    Eur J Echocardiogr; 2010 Aug; 11(7):E25. PubMed ID: 20406735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxysmal exertion-induced dystonia secondary to Erdheim-Chester disease.
    Baldacci F; Lucetti C; Vergallo A; Borelli P; Tessa C; Viacava P; Bonuccelli U
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1105-6. PubMed ID: 22980524
    [No Abstract]   [Full Text] [Related]  

  • 29. Erdheim-Chester disease with interatrial septum involvement.
    Raptis DA; Raptis CA; Jokerst C; Bhalla S
    J Thorac Imaging; 2012 Sep; 27(5):W105-7. PubMed ID: 21681117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 43-Year-Old Man With Polyuria and Bone Pain.
    Ruan GJ; Goyal G; Go RS
    Mayo Clin Proc; 2020 Feb; 95(2):e13-e18. PubMed ID: 32029098
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular involvement in Erdheim-Chester disease.
    Masci PG; Zampa V; Barison A; Lombardi M
    Int J Cardiol; 2012 Jan; 154(2):e24-6. PubMed ID: 21676475
    [No Abstract]   [Full Text] [Related]  

  • 32. [Erdheim-Chester disease: report of a case with retroperitoneal involvement treated with interferon alpha-2a].
    Gil Ortega M; López Lozano E; Girela Baena E; Navarro Martinez N
    Med Clin (Barc); 2013 Sep; 141(5):227-8. PubMed ID: 23452672
    [No Abstract]   [Full Text] [Related]  

  • 33. Erdheim-Chester disease with cardiac involvement successfully treated with anakinra.
    Killu AM; Liang JJ; Jaffe AS
    Int J Cardiol; 2013 Sep; 167(5):e115-7. PubMed ID: 23659884
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac Involvement in Erdheim-Chester Disease.
    Quinaglia-Silva T; Medina F; Ramos CD; Coelho-Filho OR
    Circ Cardiovasc Imaging; 2018 Dec; 11(12):e008531. PubMed ID: 30562109
    [No Abstract]   [Full Text] [Related]  

  • 35. Central nervous system involvement in Erdheim-Chester disease: An observational cohort study.
    Cohen Aubart F; Idbaih A; Galanaud D; Law-Ye B; Emile JF; Charlotte F; Donadieu J; Maksud P; Seilhean D; Amoura Z; Hoang-Xuan K; Haroche J
    Neurology; 2020 Nov; 95(20):e2746-e2754. PubMed ID: 32887776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erdheim-Chester disease: yellow-tinge appearance on neuroendoscopic imaging.
    Kon T; Nishijima H; Kon H; Watanabe M; Tomiyama M
    Neurol Sci; 2015 Nov; 36(11):2159-60. PubMed ID: 26173499
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.
    Roeser A; Cohen-Aubart F; Breillat P; Miyara M; Emile JF; Charlotte F; Donadieu J; Amoura Z; Haroche J
    Haematologica; 2019 Nov; 104(11):e502-e505. PubMed ID: 30923093
    [No Abstract]   [Full Text] [Related]  

  • 38. Pulmonary involvement in Erdheim-Chester disease.
    Chung JH; Park MS; Shin DH; Choe KO; Kim SK; Chang J; Kim SK; Kim YS
    Respirology; 2005 Jun; 10(3):389-92. PubMed ID: 15955155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of Erdheim-Chester disease effectively treated by cyclophosphamide and prednisolone].
    Yano S; Kobayashi K; Kato K; Tokuda Y; Ikeda T; Takeyama H
    Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):43-8. PubMed ID: 17313026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic vasculitis associated with vemurafenib treatment: Case report and literature review.
    Mirouse A; Savey L; Domont F; Comarmond C; Barete S; Plaisier E; Rouvier P; Cacoub P; Saadoun D
    Medicine (Baltimore); 2016 Nov; 95(46):e4988. PubMed ID: 27861332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.